Personalized medicine in development by type 2015

The data shows the percentage of personalized medicines in development by type as of 2015. In 2015, 42% of all drugs in development had the potential to be personalized medicines, while 73% of oncology drugs had the potential to be personalized medicines. Personalized medicines are medicines that, based on a patients biomarkers or biology, may be more a effective treatment option.